130 related articles for article (PubMed ID: 35900506)
1. Novel ALK-EML4 fusion with prominent mucous and hyaline stroma: Expanding the molecular genetic spectrum of S100 and CD34 positive spindle cell tumor.
Sun R; Hu R; Xiong J; Wang Y
Indian J Pathol Microbiol; 2022; 65(3):695-698. PubMed ID: 35900506
[TBL] [Abstract][Full Text] [Related]
2. Novel PPP1CB-ALK fusion in spindle cell tumor defined by S100 and CD34 coexpression and distinctive stromal and perivascular hyalinization.
Lopez-Nunez O; Surrey LF; Alaggio R; Fritchie KJ; John I
Genes Chromosomes Cancer; 2020 Aug; 59(8):495-499. PubMed ID: 32222087
[TBL] [Abstract][Full Text] [Related]
3. Spindle cell tumor with CD34 and S100 co-expression and distinctive stromal and perivascular hyalinization showing EML4-ALK fusion.
Abs D; Landman S; Osio A; Lepesant P; Schneider P; Obadia D; Moguelet P; Farges C; Poirot B; Lehmann-Che J; Lebbé C; Battistella M
J Cutan Pathol; 2021 Jul; 48(7):896-901. PubMed ID: 33241586
[TBL] [Abstract][Full Text] [Related]
4. Case report:
Sheng SJ; Li JM; Fan QH; Liu Y; Chen SY; Zhao M; Gong QX
Front Oncol; 2022; 12():1007296. PubMed ID: 36387173
[No Abstract] [Full Text] [Related]
5. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
[TBL] [Abstract][Full Text] [Related]
6. A novel case of cutaneous myxoid spindle cell neoplasm with FMR1-ALK gene fusion and CD34/S100 co-expression.
Kasago I; Aypar U; Sukhadia P; Vanderbilt C; Ladanyi M; Hurd T; Pulitzer M
J Cutan Pathol; 2023 Jun; 50(6):505-510. PubMed ID: 36325885
[TBL] [Abstract][Full Text] [Related]
7. S100 and CD34 positive spindle cell tumor with prominent perivascular hyalinization and a novel NCOA4-RET fusion.
Michal M; Ptáková N; Martínek P; Gatalica Z; Kazakov DV; Michalová K; Stoláriková L; Švajdler M; Michal M
Genes Chromosomes Cancer; 2019 Sep; 58(9):680-685. PubMed ID: 30938880
[TBL] [Abstract][Full Text] [Related]
8. [A new target in non-small cell lung cancer: EML4-ALK fusion gene].
Wang H; Yuan J; Ma Z
Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):538-42. PubMed ID: 21645460
[TBL] [Abstract][Full Text] [Related]
9. ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney.
Tan SY; Al-Ibraheemi A; Ahrens WA; Oesterheld JE; Fanburg-Smith JC; Liu YJ; Spunt SL; Rudzinski ER; Coffin C; Davis JL
Histopathology; 2022 Mar; 80(4):698-707. PubMed ID: 34843129
[TBL] [Abstract][Full Text] [Related]
10. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
[TBL] [Abstract][Full Text] [Related]
11. Effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer.
Kobayashi M; Sakakibara T; Inoue A; Fukuhara T; Sasano H; Ichinose M; Nukiwa T
Respir Investig; 2014 Jan; 52(1):49-56. PubMed ID: 24388371
[TBL] [Abstract][Full Text] [Related]
12. RAF1-rearranged spindle cell tumour: report of two additional cases with identification of a novel FMR1-RAF1 fusion.
Zhang T; Wang Q; Yi X; Zhu P
Virchows Arch; 2021 Dec; 479(6):1245-1253. PubMed ID: 34459981
[TBL] [Abstract][Full Text] [Related]
13. ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.
Kimura H; Nakajima T; Takeuchi K; Soda M; Mano H; Iizasa T; Matsui Y; Yoshino M; Shingyoji M; Itakura M; Itami M; Ikebe D; Yokoi S; Kageyama H; Ohira M; Nakagawara A
Lung Cancer; 2012 Jan; 75(1):66-72. PubMed ID: 21757253
[TBL] [Abstract][Full Text] [Related]
14. Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.
Noh KW; Lee MS; Lee SE; Song JY; Shin HT; Kim YJ; Oh DY; Jung K; Sung M; Kim M; An S; Han J; Shim YM; Zo JI; Kim J; Park WY; Lee SH; Choi YL
J Pathol; 2017 Nov; 243(3):307-319. PubMed ID: 28741662
[TBL] [Abstract][Full Text] [Related]
15. Going beneath the tip of the iceberg. Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC.
Zhang SS; Nagasaka M; Zhu VW; Ou SI
Lung Cancer; 2021 Aug; 158():126-136. PubMed ID: 34175504
[TBL] [Abstract][Full Text] [Related]
16. CD30 expression in an emerging group of mesenchymal spindle cell neoplasms with ALK fusion detected by flow cytometry and immunohistochemistry.
Iwakoshi A; Kikui H; Nakashima R; Goto Y; Ichikawa D; Sasaki E; Sekimizu M; Hattori H; Maeda N
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23228. PubMed ID: 38380728
[TBL] [Abstract][Full Text] [Related]
17. A spindle cell neoplasm with MYH9::EGFR fusion and co-expression of S100 and CD34, further expanding the family of kinase fusion positive spindle cell neoplasms.
Caprini E; Verkhovskaia S; Casini B; Testi A; Dagrada GP; Palese E; Rahimi S
Genes Chromosomes Cancer; 2023 Aug; 62(8):483-488. PubMed ID: 36849873
[TBL] [Abstract][Full Text] [Related]
18. New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer.
Dubey AP; Pathi N; Viswanath S; Rathore A; Pathak A; Sud R
Indian J Cancer; 2017; 54(1):203-208. PubMed ID: 29199691
[TBL] [Abstract][Full Text] [Related]
19. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
[TBL] [Abstract][Full Text] [Related]
20. Correlation of anaplastic lymphoma kinase overexpression and the EML4-ALK fusion gene in non-small cell lung cancer by immunohistochemical study.
Chen TD; Chang IC; Liu HP; Wu YC; Wang CL; Chen YT; Chen YR; Huang SF
Chang Gung Med J; 2012; 35(4):309-17. PubMed ID: 22913857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
